Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in OA Text Journals.
The publication charges for Clinical Case Reports and Reviews are GBP 3490.įrequently Asked Questions (FAQs) Why are your charges set at these levels?Īll articles published in OA Text are open access. Have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable. Systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. The process includes our maintenance, submission and peer review
Structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). In line with other open access journals we provide a flat fee submission Of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License". This allows the scientific community to view, download, distribution Goren developed a medical device to correct gait disorders in peripheral neuropathy patients using sensory substitution, as well as invent the first wire-free electric charger for mobile devices.Ĭlinical Case Reports and Reviews is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. Prior to his work in Dermatology, Professor His accomplishments include several patents and publications related to his inventions and discoveries. Interviews on mainstream TV, radio, and prestigious newspapers. He is an honoraryĪs well as ordinary member of several dermatology societies world-wide, a scientific reviewer for Dermatologic Therapy, a lecturer in several international dermatology societies, and held numerous appearances and Goren currently serves as a contract Professor of Dermatology at Universita' degliStudi di Roma "G.Marconi". The development of dermatology therapies based on genetically modified organisms. The drug, Photocil, selectively filters NB-UVB from natural sunlight thus increasing patient compliance and convenience over artificial phototherapy. FDA of a breakthrough topical drug for vitiligo, Goren recently completed the development, commercialization, and listing with the U.S. Acnes bacterial genomics, and the first to commercializeĪ rapid test for predicting minoxidil response in androgenetic alopecia. Predicting anti-androgen therapy response in female androgenetic alopecia, the first to commercialize an acne vulgaris antibiotic response test based on P. Among the list of many firsts in dermatology, Prof Goren was the first to develop a commercial genetic test for predicting androgenetic alopecia, the first to discover epigenetic markers Andy Goren has over 20 years of experience in the development and commercialization of breakthrough technologies in the medical, biotechnologyĪnd semiconductor fields. You can submit your manuscript to: alternatively to: Goren Following payment of this fee, the article will be made universally available.ĬCRR welcomes direct submissions of manuscripts from authors. If accepted for publication, authors are requested to pay an article processing fee per article. Manuscripts must be authentic, understandable, educational, and of interest to an international audience, residents, fellows, and researchers, as well as clinicians in related fields. Which illustrates an important, practical and gereralisable teaching message. Case reports do not have to be novel or unusual, but need to reflect best practice.Ĭase reports may span the full spectrum of medicine across the health sciences in the broadest sense, including all clinical medical specialties, veterinary medicine, nursing, allied health and dentistry We aim to publish high quality original case reportsĪcross all medical disciplines contributing greatly to the advancement of health care. Clinical case reports are key source of evidence in medicine and our aim is to directly improve global health and conveyĪn important teaching point about a common or important clinical scenario and generate a more expanded search for evidence.Ĭlinical Case Reports and Reviews (CCRR) is a bimonthly open access journal with a comprehensive peer review policy, and a very rapid publication process.